Rajeev Saggar
Chief Tech/Sci/R&D Officer at LIQUIDIA CORPORATION
Net worth: 3 M $ as of 2024-04-29
Rajeev Saggar active positions
| Companies | Position | Start | End |
|---|---|---|---|
| LIQUIDIA CORPORATION | Chief Tech/Sci/R&D Officer | 2022-07-17 | - |
Career history of Rajeev Saggar
Former positions of Rajeev Saggar
| Companies | Position | Start | End |
|---|---|---|---|
Theravance Biopharma US, Inc.
 Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2021-08-31 | 2022-06-30 |
| The Banner-University Medical Center | Corporate Officer/Principal | - | - |
Training of Rajeev Saggar
| University of California, Irvine | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| LIQUIDIA CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Rajeev Saggar
- Experience
